AAPath was pleased to offer Continuing Medical Education for select meeting sessions. CME was included in the meeting registration rate for physicians. Claims were for in-person or remote session attendance and on-demand viewing of the recorded sessions after the conference. By attending the programmed sessions and viewing the recordings of the concurrent sessions after the conference, participants were able to claim a maximum of 44.25AMA PRA Category 1 Credits™. Physicians should have claimed only the credit commensurate with the extent of their participation in the activity. All other CME information and disclosures are posted below.
CME Claims were due by September 30, 2024. All submissions were reviewed by staff prior to issuing CME certificates. Certificates were sent to the email address provided on the form within 4-6 weeks of claim submissions. Certificates were issued on a monthly basis through the week following the deadline of September 30, 2024. If you have any questions about your CME credits, please contact AAPath staff at info@academicpathology.org or 302-660-4940.
AAPath 2024 Annual Meeting CME Program
ACTIVITY DESCRIPTION: The AAPath 2024 Annual Meeting is an other/blended (live and recorded) learning activity that provides educational activities designed to provide training and professional development for academic pathologists.
TARGET AUDIENCE: The live session presentations and discussions and recordings of such live sessions provide educational activities for four target audiences:
Chairs, Vice Chairs, and former Chairs (Senior Fellows) of academic departments of pathology and laboratory medicine;
Program Directors and Associate Program Directors of pathology residency training programs;
Medical student educators of pathology in medical schools; and
Faculty members and trainees (fellows, residents, and medical students) aspiring to these positions.
The target audience are professionals (MD, DO, PhD) and others who serve as the academic, medical, scientific, and administrative leaders of departments of pathology and laboratory medicine in the United States and Canada.
EDUCATIONAL OBJECTIVES: The objective of the learning activity is to facilitate knowledge acquisition to enable departments to fulfill their missions in teaching, clinical service, and research. Content focuses on issues in three broad areas that address educational needs in knowledge, competency, and performance:
1. ADMINISTRATION/LEADERSHIP: Developing and refining leadership skills, including well-being, for successfully administering an academic pathology department to meet the demands of the three departmental missions within an academic health system: medical education, practice, and research.
2. PATHOLOGY CONTENT/CURRICULUM and TRAINING/TEACHING STRATEGIES: Enhancing medical education content and faculty development are given priority to develop both the content and pedagogy for the identified gaps in the continuum from undergraduate and graduate medical education, as well as continuous medical education for practicing pathologists.
3. PRACTICE/MANAGEMENT: Strategies to sustain a department include addressing (a) the laboratory workforce with evolving technology and innovations in research infrastructure, (b) the training and development of faculty, staff, and trainees, (c) diverse learning styles and health disparities in patient populations, and (d) how to locally and nationally advocate for academic pathology
ACCREDITATION STATEMENT FOR CONTINUING MEDICAL EDUCATION (CME): This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American Society of Cytopathology (ASC) and the Association for Academic Pathology (AAPath). The ASC is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT: The ASC/AAPath designates this other/blended (live and recorded) educational activity for a maximum of 44.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
RELEASE DATE: July 21, 2024 EXPIRATION DATE: September 30, 2024
DISCLOSURES: The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the ASC/AAPath and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ASC/AAPath has reviewed the disclosures as listed below and mitigated all relevant financial relationships. All other planning committee members and speakers listed below have reported no relevant financial relationships. The AAPath staff associated with the development of content for this activity reported no relevant financial relationships.
SUMMARY OF CONFLICT OF INTEREST DISCLOSURES
Name
Name of Ineligible Company
Nature of Relevant Relationship
Neil Anderson
Diasorin Molecular
Honoraria, Scientific Advisory Board
Roche
Honoraria, Scientific Advisory Board
BioRad
Honoraria, Scientific Advisory Board
James Crawford
ClaraPath
No renumeration, Non-voting Member of Board of Directors
Lea Grinberg
Celdara Medical
Honoraria, Lecturer
Michael Laposata
Werfen
Honoraria, Advisory Board
Liron Pantanowitz
Ibex
Consultant fee, Medical Advisory Board
Hamamatsu
Consultant fee, Consultant
AiXMed
Consultant fee, Consultant
The following individuals have reported no relevant financial relationships:
The Society of ’67 was established to support programs aligned with AAPath's mission and vision. Those who wish to support AAPath's mission and vision can donate to the Society of ’67.
